Niagen Bioscience (NAGE) Other Non-Current Assets (2011 - 2026)
Niagen Bioscience (NAGE) reported Other Non-Current Assets of $152000.0 for Q1 2026, little changed year-over-year from $152000.0 in Q1 2025, and little changed quarter-over-quarter from $152000.0 in Q4 2025.
Niagen Bioscience (NAGE) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 14 years of Other Non-Current Assets data on file, last reported at $152000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $152000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $152000.0 (changed 0.0% YoY), and the FY2025 annual result was $152000.0, changed 0.0% from the prior year.
- Other Non-Current Assets held at $152000.0 in Q1 2026 per NAGE's latest filing, from $152000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $417000.0 in Q3 2025 and troughed at $152000.0 in Q1 2022.
- A 5-year average of $167588.2 and a median of $152000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets fell 24.0% in 2022, then soared 174.34% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $152000.0 in 2022, then changed by 0.0% to $152000.0 in 2023, then changed by 0.0% to $152000.0 in 2024, then changed by 0.0% to $152000.0 in 2025, then changed by 0.0% to $152000.0 in 2026.
- Business Quant data shows NAGE's Other Non-Current Assets at $152000.0 in Q1 2026, $152000.0 in Q4 2025, and $417000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn | 152,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 152,000.00 |
| Dec 31, 2025 | 152,000.00 |
| Sep 30, 2025 | 417,000.00 |
| Jun 30, 2025 | 152,000.00 |
| Mar 31, 2025 | 152,000.00 |
| Dec 31, 2024 | 152,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 152,000.00 |
| Mar 31, 2024 | 152,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Sep 30, 2023 | 152,000.00 |
| Jun 30, 2023 | 152,000.00 |
| Mar 31, 2023 | 152,000.00 |
| Dec 31, 2022 | 152,000.00 |
| Sep 30, 2022 | 152,000.00 |
| Jun 30, 2022 | 152,000.00 |
| Mar 31, 2022 | 152,000.00 |
| Dec 31, 2021 | 152,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |